policy
Six disciplines of KAIST have emerged among the top 20 in the world. The 2017 QS World University Rankings by Subject rated Materials Science at KAIST 13th in the global ranking. Other subjects ranked within top 20 include Chemical and Biomolecular Engineering (15th), Civil and Environmental Engineering (15th), Mechanical and Aerospace Engineering (15th), Electrical Engineering (17th), and Chemistry (18th). This year, two more disciplines advanced into the top 20 from four in 2016.
QS ranked KAIST as the top science and technology research university in Korea. KAIST earned the highest global rankings among Korean universities in the following seven areas: Materials Science and Engineering (13th), Chemical and Biomolecular Engineering (15th), Civil and Environmental Engineering (15th), Mechanical and Aerospace Engineering (15th), Electrical Engineering (17th), Chemistry (18th), and the School of Computing (33th). In addition, two more disciplines of Physics (44th) and Mathematical Sciences (47th) were ranked second among domestic universities.
The London-based university ranking by Quacquarelli Symonds, Ltd. announced the global university ranking by 46 subjects on March 8. QS rankings are based on academic reputation, employer reputation, the number of research citations, and research accomplishment index (H-index).
-
research KAIST Develops a Multifunctional Structural Battery Capable of Energy Storage and Load Support
Structural batteries are used in industries such as eco-friendly, energy-based automobiles, mobility, and aerospace, and they must simultaneously meet the requirements of high energy density for energy storage and high load-bearing capacity. Conventional structural battery technology has struggled to enhance both functions concurrently. However, KAIST researchers have succeeded in developing foundational technology to address this issue. < Photo 1. (From left) Professor Seong Su Kim, PhD
2024-11-27 -
event KAIST Office of Global Initiative Hosts 2024 Global Startup Internship Seminar
< Photo of ImpriMed CEO Sungwon Lim’s lecture > The Office of Global Initiative at KAIST successfully hosted the 2024 Global Startup Internship Seminar (GSIS) from Wednesday, November 20, to Friday, November 22. Now in its third year, following the 2022 Global Startup Internship Fair, the GSIS aims to introduce KAIST students to internship opportunities at U.S.-based startups and encourage participation in global internship programs, particularly for students with entrepreneu
2024-11-25 -
research KAIST Secures Core Technology for Ultra-High-Resolution Image Sensors
A joint research team from Korea and the United States has developed next-generation, high-resolution image sensor technology with higher power efficiency and a smaller size compared to existing sensors. Notably, they have secured foundational technology for ultra-high-resolution shortwave infrared (SWIR) image sensors, an area currently dominated by Sony, paving the way for future market entry. KAIST (represented by President Kwang Hyung Lee) announced on the 20th of November that a research t
2024-11-22 -
event KAIST’s RAIBO2 becomes the World’s First Robo-dog to Successfully Complete a Full-course Marathon
KAIST's quadrupedal walking robot "RAIBO", which can run seamlessly on sandy beaches, has now evolved into "RAIBO2"and achieved the groundbreaking milestone by becomeing the world's first quadrupedal robot to successfully complete a full-course marathon in an official event. < Photo 1. A group photo of RAIBO2 and the team after completing the full-course marathon > KAIST (President Kwang Hyung Lee) announced on the 17th of November that Professor Je Min Hwangbo's research team of t
2024-11-17 -
research KAIST Unveils New Possibilities for Treating Intractable Brain Tumors
< Photo 1. (From left) Professor Heung Kyu Lee, KAIST Department of Biological Sciences, and Dr. Keun Bon Ku > Immunotherapy, which enhances the immune system's T cell response to eliminate cancer cells, has emerged as a key approach in cancer treatment. However, in the case of glioblastoma, an aggressive and treatment-resistant brain tumor, numerous clinical trials have failed to confirm their efficacy. Korean researchers have recently analyzed the mechanisms that cause T cell exhaus
2024-11-15